A Phase 4 interventional study of zoledronic acid vs pamidronate in Osteopenia, Complications of Heart-lung Transplant and Other Complications of Lung Transplant, sponsored by Bayside Health. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-12-05.
Sponsored by Bayside Health · Phase 4, Interventional, and Treatment
The purpose of this trial is to see whether zoledronic acid is better than pamidronate to treat low bone density in heart and lung transplant patients.
470 studies on the registry are indexed under Bone Diseases, Metabolic; 71 are open to participants now.
This study's enrollment of 56 is close to the median of 60 across 359 interventional studies indexed under Bone Diseases, Metabolic.
Browse Bone Diseases, Metabolic studies →Bayside Health is the lead sponsor of 110 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Bone mineral density of lumbar spine at 12 months as measured by DEXA.
Bone mineral density of femoral neck at 12 months as measured by DEXA.
No study locations are listed for this record.
This study is completed, as verified in Sep 2005. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bayside Health